SKI Market

Indian Indices

Nifty

25,044.35 72.45
(0.29%)

Sensex

82,055.11 158.32
( 0.19%)

Bank Nifty

56,461.90 402.55
( 0.72%)

Nifty IT

38,417.95 3.85
( 0.01%)

Global Indices

Nasdaq

43,117.37 514.58
(1.21%)

Dow Jones

6,114.62 68.45
(1.13%)

Hang Seng

38,777.68 423.59
(1.10%)

Nikkei 225

8,758.99 0.95
(0.01%)

Forex

USD-INR

86.50 -0.18
(-0.20%)

EUR-INR

99.61 0.16
(0.17%)

GBP-INR

116.27 -0.12
(-0.11%)

JPY-INR

0.59 0.00
(-0.73%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

397.4117939

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

24.65

121386.37

EPS(TTM)

Face Value()

Div & Yield %

60.97

1.06

Back

Cipla announced incorporation of subsidiary - CiplaRna GmbH' in Germany

May 29,2025

Cipla announced that Cipla (EU), UK, a wholly owned subsidiary of the Company, has incorporated a new wholly owned subsidiary named ‘CiplaRna GmbH' in Germany, effective 28 May 2025.

CiplaRna has been incorporated with the objective of establishing a laboratory for mRNA-based formulation and drug development support.

25,044.35 72.45 (0.29%)

82,055.11 158.32 ( 0.19%)

56,461.90 402.55 ( 0.72%)

38,417.95 3.85 ( 0.01%)

43,117.37 514.58 (1.21%)

6,114.62 68.45 (1.13%)

38,777.68 423.59 (1.10%)

8,758.99 0.95 (0.01%)

86.50 -0.18 (-0.20%)

99.61 0.16 (0.17%)

116.27 -0.12 (-0.11%)

0.59 0.00 (-0.73%)